Dr. Martínez Ávila is PhD in animal breeding and genetics from the Polytechnic University of Madrid. He completed his doctoral studies between 2004 and 2008 in the department of animal breeding and genetics of the national institute of agricultural research and agri-food technology, INIA,after being awarded an FPI grant and under the supervision of PhD. Luis Alberto García Cortés. During this period he learned Bayesian statistics and computer programming in C, C ++ and R needed to implement the computational aspects of his thesis, analyze together a normal (productive) trait with one that is not (survival). The proposed solution, is an approach new before the methods proposed in those years. The thesis gave him the opportunity to be in contact with foreign researchers experts in computing and Bayesian statistics field, Dr Rekaya and in the survival analysis field , Dr Sölkner. In 2008 he moved for personal reasons to Vienna, thus beginning a new stage. He worked as a biostatistician at the Medical University of Vienna, Department of Internal Medicine III, rheumatology being his direct superiors Dr Smolen and Dr Aletaha, extracting knowledge from clinical trials data and take advantage of the properties statistics of the SDAI and CDAI indices.
At the same time he began the master\'s degree in biomedical engineering at the Technical University of Vienna (TU), in the specialty of biology and computational mathematics. I come into contact with researchers in the area of computational and highly dimensional statistics such as Professor Peter Filzmoser, from whom he learned advanced statistical methods to analyze highly dimensional data, such as the omics of which metabolomics are an example of this type of data. The final master\'s work makes a review of the different statistical methods used for the study of omic data in this case applied to RNA of Alzheimer\'s patients. He worked at the pharmaceutical company Octapharma in the pharmacovigilance department. He applied his knowledge in statistics and mathematics to predict the possible adverse effects of his products, blood plasma products, before they were produced using all the available data of the company.
In April 2014 he returned to Spain joining the spanish center of cancer research, CNIO, the genetic epidemiology group of Dr. Nuria Malats investigating family and hereditary cancer.
2015 begins at the biomedical research institute of the university hospital on October 12 as a researcher of the Spanish clinical trials platform SCReN. His most important contribution is the writing of the standardized work procedures for the statistical program of this platform and a doctoral thesis. During this time articles related to the genetics of  family cancer, lymphoma and pediatrics., were published. February 2017 he joined the research group of Clinical Pharmacology of IdiPaz (Research Institute of the Hospital of La Paz) where his lines of research are focused on the application  of metabolomics and genomics to pharmacology publishing several works in pharmacometabolomics and genetics of pain. November 2019 started at CIBERSAM where Mental Health is now the topic of application of his knowledge.
September 2020 joined the San Pablo CEU university at the economics and bussines administration faculty as profesor of statistics in the applied matematics and statistics departement where develop predictive models in combination with different lectures about statistics

Since 2022 he started as assisstant professor at Agricultural Economics, Statistics and Bussiness Management department in Escuela Técnica Superior de Ingeniería Agronómica, Alimentaria y Biosistema of UPM. He teachs statistics and advances statistical methods in bachelor and master degree.  He has been director of a final degree project in biotechnology combining familiar data and mixed models. Since January 2024, he is Profesor Permamente Laboral